American International Group Inc.'s successful bid to avoid covering litigation against opioid manufacturing giant ...

But if that doesn’t happen, it’s to go into the main settlement. Other drugmakers, distribution companies, pharmacy chains and others have already reached opioid lawsuit settlements worth ...

Swiss Drugmakers Novartis and Roche Ditch Some Diversity Programmes on US Concerns By Paul Arnold, Maggie Fick ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce ...

ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies acting to ...

Bengaluru: Mallinckrodt and Endo , drugmakers with a shared history of bankruptcy and U.S. opioid litigation, will merge in a deal valued at nearly $7 billion to boost scale for selling their ...

We will always give you the option to opt out of our marketing. Wachtell Lipton Rosen & Katz and Davis Polk & Wardwell have scored lead roles on the $6.7bn merger of drugmakers Mallinckrodt and Endo.

Plus, pharmacy groups famed for opioid bankruptcies join forces and the mysterious Deutsche Bank employee making more than its CEO ...

Mallinckrodt and Endo, drugmakers with a shared history of facing bankruptcy and US opioid litigation, have agreed to merge in a deal valued at nearly $7 billion. Endo shareholders will get $80 ...

Endo and Mallinckrodt, two drugmakers seeking to recover from opioid lawsuits and bankruptcies, are betting a combination will help. Investors took a dim view Thursday. Shares of Endo fell more ...

Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York ...

Copyright 2025 The Associated Press. All Rights Reserved. This July 1, 2013, file photo, shows the exterior of the Mallinckrodt Pharmaceuticals office in St. Louis ...